Select your area of expertise
ePlex Panels
GenMark Diagnostics is committed to addressing the need to improve patient care through the design and development of comprehensive multiplex panels. Our growing infectious disease menu includes:
Detection of Omicron variant on the ePlex® RP2 Panel
Detection of variant SARS-CoV-2 strains on the ePlex RP2 Panel
Major teaching hospital in Grenoble, France demonstrates that ePlex BCID results could have modified antimicrobial treatment in 45% of patients
Rapid BCID Saved Costs and Reduced Healthcare Worker-Patient Interaction Time During the COVID-19 Pandemic
Analytical Performance to Clinical Outcomes – A Retrospective Analysis of Bacteremia Using the GenMark Dx ePlex® BCID Panels – IDWeek Presentation Theater
The Big Picture of Rapid Blood Culture ID: A Retrospective Clinical Analysis Building to a Prospective Clinical Trial
